IP Library Granted Patent US 8,679,550
Granted Patent B2
US 8,679,550 · App. 13/406,253 · Granted Mar 25, 2014

Patent

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,679,550
App. No.
13/406,253
Granted
Mar 25, 2014
Kind
B2
Abstract

Fortified food and dietary supplement products may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relates to the administration of products enhanced with plant products and iridoids. A study was performed to evaluate the iridoid content, as well as the in vitro and in vivo bioactivities, of a beverage containing noni fruit, Cornelian cherries, and olive leaf extract. The major iridoids present were identified as asperulosidic acid, deacetylasperulosidic acid, oleuropein, morroniside, loganic acid, and loganin In the 2,2-Diphenylpicrylhydrazyl (DPPH) radical scavenging assay, remarkably high in vitro antioxidant activity was observed, with an IC 50 of 3.8 μL/mL. In vivo bioactivities were evaluated in type 2 diabetic Sprague Dawley rats. In a dose-dependent manner, the composition reduced abnormal weight gain, blood glucose levels, and serum advanced glycation end products (AGEs), as well as improved immunity via increased T cell counts and CD4+/CD8 + ratios.

Claims (6)

1. A formulation comprising, by weight of the formulation:

Morinda citrifolia fruit juice in amount by weight between about 0.1 and 80 percent, Cornus mas puree in amount by weight between 0.1 and 80 percent, Cornus officinalis juice in amount by weight between 0.1 and 80 percent, Vitis vinifera juice concentrate in an amount by weight between 0.1 and 80 percent, Vaccinium corymbosum juice in an amount by weight of about 1.0 and 80 percent, Prunus cerasus juice concentrate in an amount by weight about 0.1 and 30 percent, Vitis labrusca juice concentrate in an amount by weight of about 0.1 to 30 percent, Olea europea leaf extract in an amount by weight of about 1.0 percent, Vaccinium macrocarpon juice concentrate in an amount by weight of about 1.0 percent and natural flavors in an amount by weight of about 1.0 percent.

2. A formulation comprising, by weight of the formulation:

Morinda citrifolia fruit juice in amount by weight between about 0.1 and 80 percent, Cornus mas puree in amount by weight between 0.1 and 80 percent, Vitis vinifera juice concentrate in an amount by weight between 0.1 and 80 percent, Vaccinium corymbosum juice in an amount by weight of about 1.0 and 80 percent, Prunus cerasus juice concentrate in an amount by weight about 0.1 and 30 percent, Vitis labrusca juice concentrate in an amount by weight of about 0.1 to 30 percent, Olea europea leaf extract in an amount by weight of about 1.0 percent, Vaccinium macrocarpon juice concentrate in an amount by weight of about 1.0 percent and natural flavors in an amount by weight of about 1.0 percent.

3. A formulation comprising, by weight of the formulation:

Morinda citrifolia fruit juice in amount by weight between about 0.1 and 80 percent, Cornus officinalis juice in amount by weight between 0.1 and 80 percent, Vitis vinifera juice concentrate in an amount by weight between 0.1 and 80 percent, Vaccinium corymbosum juice in an amount by weight of about 1.0 and 80 percent, Prunus cerasus juice concentrate in an amount by weight about 0.1 and 30 percent, Vitis labrusca juice concentrate in an amount by weight of about 0.1 to 30 percent, Olea europea leaf extract in an amount by weight of about 1.0 percent, Vaccinium macrocarpon juice concentrate in an amount by weight of about 1.0 percent and natural flavors in an amount by weight of about 1.0 percent.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 1, 2022
From: JGB COLLATERAL, LLC
To: MORINDA, INC.
Reel/Frame 059478/0518 →
RELEASE OF SECURITY INTEREST Recorded Dec 22, 2020
From: EAST WEST BANK
To: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES, INC.; MORINDA, INC.
Reel/Frame 054733/0587 →
RELEASE OF SECURITY INTEREST Recorded Dec 7, 2020
From: EAST WEST BANK
To: NEWAGE, INC.; NABC, INC.; MORINDA, INC.
Reel/Frame 054560/0232 →
SECURITY INTEREST Recorded Dec 1, 2020
From: ARIEL MERGER SUB 2, LLC; NEWAGE, INC. (A WASHINGTON CORPORATION); NABC, INC.; MORINDA, INC.
To: JGB COLLATERAL, LLC (A DELAWARE LIMITED LIABILITY COMPANY)
Reel/Frame 054509/0837 →
SECURITY INTEREST Recorded Apr 1, 2019
From: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES, INC.; MORINDA, INC.
To: EAST WEST BANK
Reel/Frame 048752/0082 →